Related Experiment Videos
A pediatric protocol for management of extravasation injuries
Pediatric Nursing
|July 1, 1993
Insights
Intravenous (IV) medication can cause severe harm, including skin loss and nerve damage. Children's Hospital of The King's Daughters (CHKD) developed a protocol to identify and treat IV infiltrates, preventing these complications.
Area of Science:
- Pediatric healthcare
- Patient safety
- Intravenous therapy
Background:
- Intravenous (IV) administration of bioactive agents carries risks of severe complications.
- Complications include skin loss, infection, nerve damage, and limb loss.
Purpose of the Study:
- To establish a standardized protocol for identifying and treating IV infiltrates.
- To prevent serious complications associated with IV therapy in pediatric patients.
Main Methods:
- Implementation of a new protocol at Children's Hospital of The King's Daughters (CHKD).
- Focus on uniform identification and treatment of IV infiltrates.
Main Results:
- The protocol aimed to mitigate risks such as skin loss, infection, and nerve damage.
- Standardized care is expected to improve patient outcomes.
Conclusions:
- A standardized protocol is crucial for managing IV infiltrates.
- Proactive identification and treatment are essential for patient safety in IV therapy.
Abstract:
The administration of bioactive agents through IV can lead to serious complications, including partial-or full-thickness skin loss, infection, nerve and tendon damage, or loss of limb. Children's Hospital of The King's Daughters (CHKD) implemented a protocol to uniformity identify and treat infiltrates in order to avoid these serious potential complications.